Christopher Nicholas

Christopher Nicholas, PhD (he/him/his) is DFMCH faculty whose research focuses on the clinical efficacy and therapeutic mechanisms of psychedelic (psilocybin, MDMA, 5-MeO-DMT) and other psychoactive compounds (ketamine) for addiction, PTSD, chronic pain, and depression. He is currently investigating psilocybin-assisted therapy for methamphetamine and opioid use disorders, ketamine-assisted therapy for adolescent PTSD, and the therapeutic role of memory salience and neuroplasticity post-psilocybin.

He earned his PhD in clinical psychology and neuroscience at the University of Tennessee and completed his post-doctoral fellowship in aging and multi-modal neuroimaging at the University of Wisconsin School of Medicine and Public Health and William S. Middelton Memorial Veterans Hospital.